Skip to content
Screener

Ashland ASH Specialty Additives — Selling General And Administrative Expense

Other segment segments

Unallocated And Other
$38M-22.4%
Personal Care And Household
$22M+4.8%
Intermediates And Solvents
$2M+100%

Similar metrics at other companies

Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Selling General And Administrative Expense
$40.1M+32.3%
Church & Dwight logo
CHDSpecialty Products Division — Selling General And Administrative Expense
$16.8M+14.3%
RCM Technologies logo
RCMTSpecialty Health Care — Selling General And Administrative Expense
$6.68M+12.7%
Ecolab logo
ECLGlobal Institutional & Specialty — Selling General And Administrative Expense
$421M-0.9%
Phibro Animal Health logo
PAHCMineral Nutrition — Selling General And Administrative Expense
$1.99M+0.7%
Armstrong World Industries logo
AWIMineral Fiber — Selling General And Administrative Expense
$48.7M+10.7%

Other financials

Income statement

See full
Revenue$497.0M+7.3%
Gross profit$170.0M+28.8%
Operating income$43.0M+106%
Net income$16.0M+102%
EPS (diluted)$0.35+102%

Balance sheet

See full
Cash & equivalents$440.0M+113%
Total debt$1.5B-0.6%
Total equity$1.9B-1.0%
Total assets$4.6B-0.9%

Cash flow

See full
Operating cash flow$120.0M+4.3%
CapEx$20.0M0.0%
Free cash flow$100.0M+5.3%

Valuation

See full
Market cap$3.32B+40.6%
Enterprise value$4.35B+19.7%
P/E165.9×
P/S1.8×+0.5×

Profitability

See full
Gross margin31.5%+1.4pp
Operating margin4.1%
Net margin1.1%+0.5pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity1.1%+0.5pp
Debt / equity0.8×0.0×
Current ratio+0.4×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Ashland’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:17 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324226
(In millions - unaudited)Three months ended / June 30 / 2026Three months ended / June 30 / 2025Nine months ended / June 30 / 2026Nine months ended / June 30 / 2025
Selling, general and administrative expense
Life Sciences$20$18$61$58
Personal Care22216362
Specialty Additives17175049
Intermediates2164
Total operating segments6157180173
Unallocated and other38498495
$99$106$264$268

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Ashland's specialty additives — selling general and administrative expense?
Ashland (ASH) reported specialty additives — selling general and administrative expense of $17M in Q2 2026.
How has Ashland's specialty additives — selling general and administrative expense changed year-over-year?
Ashland's specialty additives — selling general and administrative expense decreased by 0.0% year-over-year, from $17M to $17M.
What is the long-term trend for Ashland's specialty additives — selling general and administrative expense?
Over 2 years (2023 to 2025), Ashland's specialty additives — selling general and administrative expense has grown at a -2.3% compound annual growth rate (CAGR), from $66M to $63M.
What does specialty additives — selling general and administrative expense mean?
This metric captures the indirect operating costs required to support the segment, including sales commissions, marketing, administrative salaries, and general overhead. It reflects the company's investment in supporting its business model and maintaining corporate infrastructure. Efficient management of these expenses is crucial for maintaining operating margins during periods of revenue volatility.

Ask your AI about Ashland's specialty additives — selling general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude